Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Spike (BA.2.12.1, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) . As the first step of the viral replication, the virus attaches to the host cell surface before entering the cell. The viral Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer protection against the viral infection. Omicron Variant was identified in South Africa in November of 2021. This variant has a large number of mutations that allow the virus to spread more easily and quickly than other variants. As of May 2022, Omicron variants have been divided into seven distinct sub-lineages: BA.1, BA.1.1, BA.2, BA.3, BA.2.12.1, BA.4, and BA.5.The Spike (BA.2.12.1, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentiviruses were produced with SARS-CoV-2 BA.2.12.1 Variant Spike (Genbank Accession #QHD43416.1 containing all the BA.2.12.1 mutations; see below for details) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions contain the eGFP gene driven by a CMV promoter (Figure 1), therefore, the spike-mediated cell entry can be determined via eGFP fluorescence. The Spike (BA.2.12.1, Omicron Variant) (SARS-CoV-2) pseudotyped lentivirus can be used to measure the activity of neutralizing antibody against SARS-CoV-2 BA.2.12.1 variant in a Biosafety Level 2 facility.As shown in Figures 2, the Spike Omicron BA.2.12.1 pseudovirus has been validated for use with target cells ACE2-HEK293 (which overexpress ACE2; BPS Bioscience #79951) .Spike Mutations in BA.2.12.1 Variant:T19I, LPPA24-27S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452Q, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, S704L, N764K, D796Y, Q954H, N969KFigure 1. Schematic of the eGFP Reporter in Spike (BA.2.12.1, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus

Product Specifications

Applications

Screen neutralizing antibodies against the SARS-CoV-2 BA.2.12.1 variant in ACE2-HEK293 cells

Shipping Conditions

-80°C

Storage Conditions

Lentiviruses are shipped with dry ice. For long term storage, it is recommended to store the virus at -80°C.

Notes

BiosafetyNone of the HIV genes (gag, pol, rev) will be expressed in the transduced cells, as they are expressed from packaging plasmids lacking the packing signal. Although the pseudotyped lentiviruses are replication-incompetent, they require the use of a Biosafety Level 2 facility. BPS recommends following all local federal, state, and institutional regulations and using all appropriate safety precautions.License DisclosureVisitbpsbioscience.com/licensefor the label license and other key information about this product.Troubleshooting GuideVisitbpsbioscience.com/lentivirus-faqfor detailed troubleshooting instructions. For all further questions, please email[email protected].

Formulation

The lentiviruses were produced from HEK293T cells. Supplied in medium containing 90% DMEM + 10% FBS.

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Acetyl-L-homoserine lactone
sc-391455 5 mg

Acetyl-L-homoserine lactone

Ask
View Details
HIF-prolyl Hydroxylase4 (PH-4) control peptide
PH42-P 100 µg

HIF-prolyl Hydroxylase4 (PH-4) control peptide

Ask
View Details
ACOT1 Polyclonal Antibody
MBS9242613-01 0.1 mL

ACOT1 Polyclonal Antibody

Ask
View Details
ACOT1 Polyclonal Antibody
MBS9242613-02 5x 0.1 mL

ACOT1 Polyclonal Antibody

Ask
View Details
Recombinant Human CD81/ TAPA-1 Protein, His, Yeast-1mg
QP5797-ye-1mg 1mg

Recombinant Human CD81/ TAPA-1 Protein, His, Yeast-1mg

Ask
View Details
InVivoMAb Anti-Human CTGF/CCN2 (Iv0075)
VHD82301 100 μg

InVivoMAb Anti-Human CTGF/CCN2 (Iv0075)

Ask
View Details